Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / articles / DOCS - DOCS INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Doximity Inc. Investors with Substantial Losses Have Opportunity to Lead Case | Benzinga


DOCS - DOCS INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Doximity Inc. Investors with Substantial Losses Have Opportunity to Lead Case | Benzinga

  • SAN DIEGO, May 16, 2024 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Doximity, Inc. (NYSE:DOCS) common stock between February 9, 2022 and April 1, 2024, inclusive (the "Class Period"), have until June 17, 2024 to seek appointment as lead plaintiff of the Doximity class action lawsuit. Captioned Kissler v. Doximity, Inc., No. 24-cv-02281 (N.D. Cal.), the Doximity class action lawsuit charges Doximity as well as certain of Doximity's top executives with violations of the Securities Exchange Act of 1934.

    If you suffered substantial losses and wish to serve as lead plaintiff of the Doximity class action lawsuit, please provide your information here:

    https://www.rgrdlaw.com/cases-doximity-inc-class-action-lawsuit-docs.html

    You can also contact attorneys J.C. Sanchez or Jennifer N. Caringal of Robbins Geller by calling 800/449-4900 or via e-mail at info@rgrdlaw.com. Lead plaintiff motions for the Doximity class action lawsuit must be filed with the court no later than June 17, 2024.

    CASE ALLEGATIONS: Doximity operates a digital platform that provides connections between, medical information to, and patient scheduling tools for medical professionals.

    The Doximity class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that defendants repeatedly touted Doximity's business prospects and the sustainability of Doximity's revenue growth and profitability, while downplaying the impact of competition ...

    Full story available on Benzinga.com

  • Stock Information

    Company Name: Doximity Inc. Class A
    Stock Symbol: DOCS
    Market: NYSE
    Website: doximity.com

    Menu

    DOCS DOCS Quote DOCS Short DOCS News DOCS Articles DOCS Message Board
    Get DOCS Alerts

    News, Short Squeeze, Breakout and More Instantly...